{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:04:34Z","timestamp":1792440274086,"version":"4.5.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People living with HIV (PLHIV) are at a high risk of developing HPV-related cancers. HPV-related malignancies occur frequently and\/or are high among PLHIV, with cervical cancer as a designated AIDS-defining condition. We aimed to explore the evidence on the interplay of HIV and HPV-related cancers in sub-Saharan Africa (SSA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The scoping review was guided by Arksey and O\u2019Malley\u2019s framework. We searched for literature from the following databases: PubMed; World Health Organization (WHO) Library; Science Direct; Google Scholar and EBSCOhost (Academic search complete, Health Source: Nursing\/Academic Edition, CINAHL). Studies reporting on evidence HIV and HPV-related cancers interplay in SSA were eligible for inclusion in this review. The Mixed Methods Appraisal Tool (MMAT) tool was used to assess the risk of bias of the included studies. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was used for reporting the search results. Thematic analysis used to reveal the emerging themes from the included studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 74 potentially eligible articles were screened. Of these, nine (7 reviews, 1 transversal case controls, and 1 quantitative study) were eligible for data extraction. The studies reported about a total of 16,351 participants in different settings. The nine included studies showed evidence of cervical cancer among HIV-infected women and distribution of HPV infection and cervical abnormalities among HIV-positive individuals. In the four studies generalizing about HIV and anal cancer, only one reported about HPV. Two studies generally reported about HIV and head and neck cancers and one reported about interaction of HIV with vaginal cancer, vulvar cancer, and penile cancer, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HIV positivity is associated with increased prevalence of HPV infection on different anatomic sites, which will result in increased burden of HPV-related cancers among PLHIV. Furthermore, primary studies with robust study designs aimed at investigating the risk developing HPV-related cancers among PLHIV are recommended.<\/jats:p>\n                    <jats:p>Systematic review registration: PROSPERO CRD42017062403<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-020-01354-1","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:04:14Z","timestamp":1587553454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa: scoping review"],"prefix":"10.1186","volume":"9","author":[{"given":"Kabelo Matjie Bridget","family":"Lekoane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond","family":"Kuupiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tivani P.","family":"Mashamba-Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Themba G.","family":"Ginindza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"issue":"9581","key":"1354_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"AE Grulich","year":"2007","unstructured":"Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59\u201367.","journal-title":"Lancet."},{"issue":"suppl 3","key":"1354_CR2","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","volume":"24","author":"DM Parkin","year":"2006","unstructured":"Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine. 2006;24(suppl 3):S11\u201325.","journal-title":"Vaccine."},{"key":"1354_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/oxfordjournals.jncimonographs.a003484","volume":"31","author":"ML Gillison","year":"2003","unstructured":"Gillison ML, Shah KV. Chapter 9: role of mucosal human papillomavirus in non-genital cancers. J Natl Cancer Inst Monogram. 2003;31:57\u201365.","journal-title":"J Natl Cancer Inst Monogram."},{"issue":"18","key":"1354_CR4","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/jnci\/92.18.1500","volume":"92","author":"M Frisch","year":"2000","unstructured":"Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000;92(18):1500\u201310.","journal-title":"J Natl Cancer Inst."},{"issue":"6","key":"1354_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/jnci\/dji072","volume":"97","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97(6):425\u201332.","journal-title":"J Natl Cancer Inst."},{"issue":"22","key":"1354_CR6","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","volume":"92","author":"International Collaboration on HIV and Cancer","year":"2000","unstructured":"International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus infected adults. J Natl Cancer Inst. 2000;92(22):1823\u201330.","journal-title":"J Natl Cancer Inst."},{"issue":"13","key":"1354_CR7","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","volume":"285","author":"M Frisch","year":"2001","unstructured":"Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285(13):1736\u201345.","journal-title":"JAMA."},{"key":"1354_CR8","doi-asserted-by":"crossref","unstructured":"Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst Monog .1998 ;( 23):15 \u201320.","DOI":"10.1093\/oxfordjournals.jncimonographs.a024166"},{"key":"1354_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/oxfordjournals.jncimonographs.a003481","volume":"31","author":"JM Palefsky","year":"2003","unstructured":"Palefsky JM, Holly EA. Chapter 6: immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogram. 2003;31:41\u20136.","journal-title":"J Natl Cancer Inst Monogram."},{"key":"1354_CR10","doi-asserted-by":"crossref","unstructured":"Silverberg MJ, Abrams DI. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era. Current Opinion in Oncology 2007; 19:446\u2013451. [PubMed: 17762569].","DOI":"10.1097\/CCO.0b013e3282c8c90d"},{"key":"1354_CR11","doi-asserted-by":"crossref","unstructured":"Silverberg MJ, Neuhaus J, Bower M, et al. Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS 2007; 21(14):1957\u20131963. [PubMed: 17721103].","DOI":"10.1097\/QAD.0b013e3282ed6338"},{"key":"1354_CR12","unstructured":"UNAIDS (2017) 'Ending AIDS: Progress towards the 90-90-90 targets'."},{"issue":"7","key":"1354_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7326\/M14-2768","volume":"163","author":"MJ Silverberg","year":"2015","unstructured":"Silverberg MJ, Lau B, Achenbach CJ, et al. Cumulative incidence of cancer among persons with HIV in North America: a cohort study. Ann Intern Med. 2015;163(7):507\u201318.","journal-title":"Ann Intern Med."},{"key":"1354_CR14","doi-asserted-by":"crossref","unstructured":"Coghill AE, Shiels MS, Suneja G, Engels EA. Elevated cancer-specific mortality among HIV-infected patients in the United States. J Clin Oncol. 2015;33(21):2376\u20132383. [PMC free article] [PubMed].","DOI":"10.1200\/JCO.2014.59.5967"},{"issue":"12","key":"1354_CR15","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/jnci\/djm010","volume":"99","author":"RJ Biggar","year":"2007","unstructured":"Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Institute. 2007;99(12):962\u201372 [PubMed: 17565153]. This paper is an assessment of the link between level of immunosuppression and risk of several AIDs-defining cancers including cervical cancer.","journal-title":"J Natl Cancer Institute"},{"key":"1354_CR16","doi-asserted-by":"crossref","unstructured":"Diamond C, Taylor TH, Aboumrad T, et al. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sexually Transmitted Dis 2005; 32(5):314\u2013320. [PubMed: 15849533].","DOI":"10.1097\/01.olq.0000162366.60245.02"},{"key":"1354_CR17","doi-asserted-by":"crossref","unstructured":"Bower M, Powles T, Newsom-Davis T, et al. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquired Immune Deficiency Syndromes 2004; 37(5):1563\u20131565. [PubMed: 15577408].","DOI":"10.1097\/00126334-200412150-00004"},{"issue":"19","key":"1354_CR18","first-page":"1915","volume":"256","author":"LA Koutsky","year":"2007","unstructured":"Koutsky LA, FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. NEJM. 2007;256(19):1915\u201327.","journal-title":"NEJM"},{"key":"1354_CR19","doi-asserted-by":"crossref","unstructured":"Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. NEJM 2007; 356(19):1928\u20131943. [PubMed: 17494926].","DOI":"10.1056\/NEJMoa061760"},{"issue":"5","key":"1354_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/CCO.0b013e3283094ed8","volume":"20","author":"E Stier","year":"2008","unstructured":"Stier E. Human papillomavirus related diseases in HIV-infected individuals. CurrOpinOncol. 2008;20(5):541\u20136. https:\/\/doi.org\/10.1097\/CCO.0b013e3283094ed8.","journal-title":"CurrOpinOncol"},{"key":"1354_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/bjc.2012.256","volume":"107","author":"M Hendry","year":"2012","unstructured":"Hendry M, Pasterfield D, Lewis R, et al. Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing. Br J Cancer. 2012;107:243\u201354.","journal-title":"Br J Cancer"},{"key":"1354_CR22","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.1016\/j.vaccine.2013.08.091","volume":"31","author":"M Hendry","year":"2013","unstructured":"Hendry M, Lewis R, Clements A, et al. \u201cHPV? Never heard of it!\u201d: a systematic review of girls\u2019 and parents\u2019 information needs, views and preferences about human papillomavirus vaccination. Vaccine. 2013;31:5152\u201367.","journal-title":"Vaccine"},{"key":"1354_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13643-017-0623-3","volume":"6","author":"Lekoane","year":"2017","unstructured":"Lekoane, et al. Mapping evidence on the burden of human papillomavirus-related cancers in sub-Saharan Africa: scoping review protocol. Syst Rev. 2017;6:229. https:\/\/doi.org\/10.1186\/s13643-017-0623-3.","journal-title":"Syst Rev"},{"issue":"1","key":"1354_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodology. 2005;8(1):19\u201332.","journal-title":"Int J Soc Res Methodology."},{"issue":"1","key":"1354_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1748-5908-5-69","volume":"5","author":"D Levac","year":"2010","unstructured":"Levac D, Colquhoun H, O'Brien KK. Scoping studies: advancing the methodology. Implementation Science. 2010;5(1):69.","journal-title":"Implementation Science"},{"key":"1354_CR26","first-page":"1","volume-title":"Proposal: a mixed methods appraisal tool for systematic mixed studies reviews","author":"P Pluye","year":"2011","unstructured":"Pluye P, et al. Proposal: a mixed methods appraisal tool for systematic mixed studies reviews. Montr\u00e9al: McGill University; 2011. p. 1\u20138."},{"issue":"1","key":"1354_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev."},{"issue":"2","key":"1354_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11912-010-0084-5","volume":"12","author":"DJ Adelstein","year":"2010","unstructured":"Adelstein DJ, Rodriguez CP. Human papillomavirus: changing paradigms in oropharyngeal cancer. Current oncology reports. 2010;12(2):115\u201320.","journal-title":"Current oncology reports."},{"issue":"1","key":"1354_CR29","first-page":"17","volume":"94","author":"CR Atlin","year":"2016","unstructured":"Atlin CR, Chung J, Goldstein D, Johnson-Obaseki S, Bloom JA, Jaakkimainen L, et al. Assessing the need for an educational intervention for primary care practitioners on HPV-related oropharyngeal cancer. University of Toronto Med J. 2016;94(1):17\u201321.","journal-title":"University of Toronto Med J"},{"key":"1354_CR30","doi-asserted-by":"crossref","unstructured":"Auluck A, Hislop G, Bajdik C, Poh C, Lewei Z, Rosin M. Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population. Cancer (0008543X).2010;116(11):2635-2644.","DOI":"10.1002\/cncr.25087"},{"issue":"18","key":"1354_CR31","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1093\/jnci\/djt260","volume":"105","author":"A Azvolinsky","year":"2013","unstructured":"Azvolinsky A. Concerned about HPV-related cancer rise, researchers advocate boosting HPV vaccination rates. JNCI: Journal of the National Cancer Institute. 2013;105(18):1335\u20136.","journal-title":"JNCI: Journal of the National Cancer Institute."},{"issue":"1","key":"1354_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pbj.2016.03.007","volume":"1","author":"HM Barroca","year":"2016","unstructured":"Barroca HM, Pontes P, Amendoeira IM. Anal HR-HPV prevalence assessed with the cobas\u00ae HPV test in an HIV-infected population of men who have sex with men. Porto Biomedical Journal. 2016;1(1):29\u201331.","journal-title":"Porto Biomedical Journal."},{"issue":"12","key":"1354_CR33","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1016\/j.ajpath.2014.08.004","volume":"184","author":"L Barzon","year":"2014","unstructured":"Barzon L, Cappellesso R, Peta E, Militello V, Sinigaglia A, Fassan M, et al. Profiling of expression of human papillomavirus-related cancer miRNAs in penile squamous cell carcinomas. The American Journal of Pathology. 2014;184(12):3376\u201383.","journal-title":"The American Journal of Pathology."},{"key":"1354_CR34","doi-asserted-by":"crossref","unstructured":"Beachler DC, Weber KM, Margolick JB, Strickler HD, Cranston RD, Burk RD, et al. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiology and Prevention Biomarkers. 2011.","DOI":"10.1158\/1055-9965.EPI-11-0734"},{"issue":"4","key":"1354_CR35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.otc.2012.04.005","volume":"45","author":"SR Best","year":"2012","unstructured":"Best SR, Niparko KJ, Pai SI. Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers. Otolaryngologic Clinics of North America. 2012;45(4):807\u201322.","journal-title":"Otolaryngologic Clinics of North America."},{"issue":"12","key":"1354_CR36","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.oraloncology.2014.09.011","volume":"50","author":"DC Beachler","year":"2014","unstructured":"Beachler DC, Abraham AG, Silverberg MJ, Jing Y, Fakhry C, Gill MJ, et al. Incidence and risk factors of HPV-related and HPV-unrelated head and neck squamous cell carcinoma in HIV-infected individuals. Oral oncology. 2014;50(12):1169\u201376.","journal-title":"Oral oncology."},{"issue":"Suppl 1","key":"1354_CR37","first-page":"S65","volume":"40","author":"VL Biron","year":"2011","unstructured":"Biron VL, Cote DW, Seikaly H. Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association. J Otolaryngol Head Neck Surg. 2011;40(Suppl 1):S65\u20139.","journal-title":"J Otolaryngol Head Neck Surg."},{"issue":"9","key":"1354_CR38","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/ijc.30243","volume":"139","author":"C Bodelon","year":"2016","unstructured":"Bodelon C, Untereiner ME, Machiela MJ, Vinokurova S, Wentzensen N. Genomic characterization of viral integration sites in HPV-related cancers. Int J Cancer. 2016;139(9):2001\u201311.","journal-title":"Int J Cancer."},{"issue":"32","key":"1354_CR39","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1016\/j.vaccine.2011.05.018","volume":"29","author":"I Borget","year":"2011","unstructured":"Borget I, Abramowitz L, Mathevet P. Economic burden of HPV-related cancers in France. Vaccine. 2011;29(32):5245\u20139.","journal-title":"Vaccine."},{"issue":"4","key":"1354_CR40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"F Bosch","year":"2002","unstructured":"Bosch F, Lorincz A, Munoz N, Meijer C, Shah K. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244\u201365.","journal-title":"J Clin Pathol"},{"issue":"11","key":"1354_CR41","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","volume":"87","author":"FX Bosch","year":"1995","unstructured":"Bosch FX, Manos MM, Mu\u00f1oz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. JNCI: Journal of the National Cancer Institute. 1995;87(11):796\u2013802.","journal-title":"JNCI: Journal of the National Cancer Institute."},{"issue":"4 Suppl","key":"1354_CR42","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.jadohealth.2010.01.016","volume":"46","author":"AK Chaturvedi","year":"2010","unstructured":"Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolescent Health. 2010;46(4 Suppl):S20\u20136.","journal-title":"J Adolescent Health"},{"issue":"4","key":"1354_CR43","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","volume":"26","author":"AK Chaturvedi","year":"2008","unstructured":"Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus\u2013related and\u2013unrelated oral squamous cell carcinomas in the United States. Journal of clinical oncology. 2008;26(4):612\u20139.","journal-title":"Journal of clinical oncology."},{"issue":"16","key":"1354_CR44","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/jnci\/djp205","volume":"101","author":"AK Chaturvedi","year":"2009","unstructured":"Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS. Journal of the National Cancer Institute. 2009;101(16):1120\u201330.","journal-title":"Journal of the National Cancer Institute."},{"issue":"4","key":"1354_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1053\/j.scrs.2005.04.003","volume":"15","author":"C L-m","year":"2004","unstructured":"L-m C, Rubin M, Smith-McCune K. Screening and treatment of HPV-related diseases in gynecologic practice. Seminars Colon Rectal Surg. 2004;15(4):201\u20139.","journal-title":"Seminars Colon Rectal Surg"},{"issue":"2","key":"1354_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12250-015-3600-9","volume":"30","author":"LT Chow","year":"2015","unstructured":"Chow LT. Model systems to study the life cycle of human papillomaviruses and HPV-associated cancers. Virologica Sinica. 2015;30(2):92\u2013100.","journal-title":"Virologica Sinica."},{"issue":"4","key":"1354_CR47","doi-asserted-by":"publisher","first-page":"e5948-e","DOI":"10.1097\/MD.0000000000005948","volume":"96","author":"N Clemente","year":"2017","unstructured":"Clemente N, Alessandrini L, Vaccher E, De Paoli A, Buttignol M, Canzonieri V, et al. Multiple preinvasive and invasive HPV-related lesions of the anogenital tract in a female patient with HIV infection: a case report. Medicine. 2017;96(4):e5948-e.","journal-title":"Medicine"},{"issue":"7","key":"1354_CR48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/sextrans-2011-050161","volume":"88","author":"EL Conway","year":"2012","unstructured":"Conway EL, Farmer KC, Lynch WJ, Rees GL, Wain G, Adams J. Quality of life valuations of HPV-associated cancer health states by the general population. Sexually transmitted infections. 2012;88(7):517\u201321.","journal-title":"Sexually transmitted infections."},{"issue":"2","key":"1354_CR49","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.seminoncol.2014.12.028","volume":"42","author":"J Dillner","year":"2015","unstructured":"Dillner J. Prevention of human papillomavirus-associated cancers. Semin Oncol. 2015;42(2):272\u201383.","journal-title":"Semin Oncol."},{"issue":"19","key":"1354_CR50","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1056\/NEJMoa065497","volume":"356","author":"G D'souza","year":"2007","unstructured":"D'souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. New England Journal of Medicine. 2007;356(19):1944\u201356.","journal-title":"New England Journal of Medicine."},{"issue":"4","key":"1354_CR51","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.idc.2013.09.001","volume":"27","author":"EF Dunne","year":"2013","unstructured":"Dunne EF, Park IU. HPV and HPV-associated diseases. Infectious Disease Clinics of North America. 2013;27(4):765\u201378.","journal-title":"Infectious Disease Clinics of North America."},{"issue":"11","key":"1354_CR52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1371\/journal.pone.0078718","volume":"8","author":"Y-H Joo","year":"2013","unstructured":"Joo Y-H, Lee Y-S, Cho K-J, Park J-O, Nam I-C, Kim C-S, et al. Characteristics and prognostic implications of high-risk HPV-associated hypopharyngeal cancers. PLoS ONE. 2013;8(11):16.","journal-title":"PLoS ONE."},{"issue":"1","key":"1354_CR53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/01.NAJ.0000511541.38888.d3","volume":"117","author":"A Katz","year":"2017","unstructured":"Katz A. CE: Human papillomavirus-related oral cancers: the nurse\u2019s role in mitigating stigma and dispelling myths. The American Journal of Nursing. 2017;117(1):34\u20139.","journal-title":"The American Journal of Nursing."},{"issue":"2","key":"1354_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/QCO.0b013e3283229fc8","volume":"22","author":"A Kreuter","year":"2009","unstructured":"Kreuter A, Wieland U. Human papillomavirus-associated diseases in HIV-infected men who have sex with men. Current opinion in infectious diseases. 2009;22(2):109\u201314.","journal-title":"Current opinion in infectious diseases."},{"issue":"4","key":"1354_CR55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2217\/17455057.4.4.357","volume":"4","author":"A Krishnan","year":"2008","unstructured":"Krishnan A, Levine AM. Malignancies in women with HIV infection. Women\u2019s Health (London, England). 2008;4(4):357\u201368.","journal-title":"Women\u2019s Health (London, England)"},{"issue":"23","key":"1354_CR56","doi-asserted-by":"publisher","first-page":"6833","DOI":"10.1158\/0008-5472.CAN-14-0602-T","volume":"74","author":"C Levovitz","year":"2014","unstructured":"Levovitz C, Chen D, Ivansson E, Gyllensten U, Finnigan JP, Alshawish S, et al. TGFbeta receptor 1: an immune susceptibility gene in HPV-associated cancer. Cancer Res. 2014;74(23):6833\u201344.","journal-title":"Cancer Res"},{"issue":"4","key":"1354_CR57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12032-015-0560-8","volume":"32","author":"C-Y Liu","year":"2015","unstructured":"Liu C-Y, Li F, Zeng Y, M-z T, Huang Y, Li J-T, et al. Infection and integration of high-risk human papillomavirus in HPV-associated cancer cells. Med Oncol (Northwood, London, England). 2015;32(4):109.","journal-title":"Med Oncol (Northwood, London, England)"},{"issue":"4","key":"1354_CR58","first-page":"S2","volume":"108","author":"EJ Mayeaux Jr","year":"2008","unstructured":"Mayeaux EJ Jr. Reducing the economic burden of HPV-related diseases. JAOA. 2008;108(4):S2\u20137.","journal-title":"JAOA"},{"issue":"1","key":"1354_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.oraloncology.2013.10.009","volume":"50","author":"MF Meyer","year":"2014","unstructured":"Meyer MF, Huebbers CU, Siefer OG, Vent J, Engbert I, Eslick GD, et al. Prevalence and risk factors for oral human papillomavirus infection in 129 women screened for cervical HPV infection. Oral Oncology. 2014;50(1):27\u201331.","journal-title":"Oral Oncology."},{"key":"1354_CR60","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.oraloncology.2017.02.024","volume":"67","author":"H Mirghani","year":"2017","unstructured":"Mirghani H, Sturgis EM, Aup\u00e9rin A, Monsonego J, Blanchard P. Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: a systematic review? Oral Oncology. 2017;67:138\u201345.","journal-title":"Oral Oncology."},{"key":"1354_CR61","doi-asserted-by":"crossref","unstructured":"Nelson RA, Lai LL. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer. Cancer. 2017.","DOI":"10.1002\/cncr.30828"},{"key":"1354_CR62","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ypmed.2016.06.041","volume":"90","author":"F Neumann","year":"2016","unstructured":"Neumann F, J\u00e9gu J, Mougin C, Pr\u00e9tet J-L, Guizard A-V, Lap\u00f4tre-Ledoux B, et al. Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: a population-based study. Preventive Medicine. 2016;90:52\u20138.","journal-title":"Preventive Medicine."},{"key":"1354_CR63","doi-asserted-by":"crossref","unstructured":"Nicol AF, Monsonego J, editors. Summary of the Eurogin 2011 conference: highlighting the recent advances in HPV-related cancers.2011\/11.","DOI":"10.1016\/j.ygyno.2011.09.009"},{"issue":"12","key":"1354_CR64","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.oraloncology.2012.06.019","volume":"48","author":"M O\u2019rorke","year":"2012","unstructured":"O\u2019rorke M, Ellison M, Murray L, Moran M, James J, Anderson L. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol. 2012;48(12):1191\u2013201.","journal-title":"Oral Oncol"},{"key":"1354_CR65","doi-asserted-by":"publisher","first-page":"E80","DOI":"10.5888\/pcd11.130361","volume":"11","author":"AP Ortiz","year":"2014","unstructured":"Ortiz AP, Perez-Irizarry J, Soto-Salgado M, Suarez E, Perez N, Cruz M, et al. Human papillomavirus-related cancers among people living with AIDS in Puerto Rico. Prev Chronic Dis. 2014;11:E80.","journal-title":"Prev Chronic Dis."},{"key":"1354_CR66","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S1201-9712(07)60015-0","volume":"11","author":"J Paavonen","year":"2007","unstructured":"Paavonen J. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias. International Journal of Infectious Diseases. 2007;11:S3\u20139.","journal-title":"International Journal of Infectious Diseases."},{"issue":"1","key":"1354_CR67","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/COH.0b013e32831a7246","volume":"4","author":"J Palefsky","year":"2009","unstructured":"Palefsky J. Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS. 2009;4(1):52\u20136.","journal-title":"Curr Opin HIV AIDS."},{"issue":"3","key":"1354_CR68","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0738-081X(96)00155-1","volume":"15","author":"JM Palefsky","year":"1997","unstructured":"Palefsky JM. Cutaneous and genital HPV-associated lesions in HIV-infected patients. Clin Dermatol. 1997;15(3):439\u201347.","journal-title":"Clin Dermatol."},{"issue":"1","key":"1354_CR69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/COH.0000000000000336","volume":"12","author":"JM Palefsky","year":"2017","unstructured":"Palefsky JM. Human papillomavirus-associated anal and cervical cancers in HIV-infected individuals: incidence and prevention in the antiretroviral therapy era. Curr Opin HIV AIDS. 2017;12(1):26\u201330.","journal-title":"Curr Opin HIV AIDS."},{"issue":"10","key":"1354_CR70","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.NURSE.0000388306.55577.8f","volume":"40","author":"L Schiech","year":"2010","unstructured":"Schiech L. Hpv-related cancer: an equal opportunity danger. Nursing. 2010;40(10):22\u20139.","journal-title":"Nursing."},{"issue":"3","key":"1354_CR71","doi-asserted-by":"publisher","first-page":"E127","DOI":"10.9778\/cmajo.20140005","volume":"2","author":"L Shack","year":"2014","unstructured":"Shack L, Lau HY, Longlong H, Doll C, Hao D. Trends in the incidence of human papillomavirus-related noncervical and cervical cancers in Alberta, Canada: a population-based study. CMAJ Open. 2014;2(3):E127\u2013E32.","journal-title":"CMAJ Open."},{"issue":"3","key":"1354_CR72","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ajog.2015.03.034","volume":"213","author":"EA Stier","year":"2015","unstructured":"Stier EA, Sebring MC, Mendez AE, Ba FS, Trimble DD, Chiao EY. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review. American Journal of Obstetrics and Gynecology. 2015;213(3):278\u2013309.","journal-title":"American Journal of Obstetrics and Gynecology."},{"issue":"1","key":"1354_CR73","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/0022034511399914","volume":"23","author":"S Syrj\u00e4nen","year":"2011","unstructured":"Syrj\u00e4nen S. Human papillomavirus infection and its association with HIV. Advances in dental research. 2011;23(1):84\u20139.","journal-title":"Advances in dental research."},{"issue":"2","key":"1354_CR74","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.canlet.2014.06.003","volume":"351","author":"ML Tornesello","year":"2014","unstructured":"Tornesello ML, Perri F, Buonaguro L, Ionna F, Buonaguro FM, Caponigro F. HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches. Cancer letters. 2014;351(2):198\u2013205.","journal-title":"Cancer letters."},{"issue":"8","key":"1354_CR75","first-page":"401","volume":"71","author":"RP Van der Zee","year":"2013","unstructured":"Van der Zee RP, Richel O, De Vries H, Prins JM. The increasing incidence of anal cancer: can it be explained by trends in risk groups. The Netherlands journal of medicine. 2013;71(8):401\u201311.","journal-title":"The Netherlands journal of medicine."},{"issue":"2","key":"1354_CR76","first-page":"0","volume":"31","author":"D Vivenza","year":"2016","unstructured":"Vivenza D, Lo Nigro C, Denaro N, Fortunato M, Monteverde M, Tonissi F, et al. E1 detection as prognosticator in human papillomavirus-positive head and neck cancers. Int J Biol Markers. 2016;31(2):0.","journal-title":"Int J Biol Markers"},{"issue":"6","key":"1354_CR77","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1159\/000477252","volume":"40","author":"S Wagner","year":"2017","unstructured":"Wagner S, Sharma SJ, Wuerdemann N, Knuth J, Reder H, Wittekindt C, et al. Human papillomavirus-related head and neck cancer. Oncol Res Treat. 2017;40(6):334\u201340.","journal-title":"Oncol Res Treat"},{"issue":"9","key":"1354_CR78","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s11912-014-0402-4","volume":"16","author":"K Wakeham","year":"2014","unstructured":"Wakeham K, Kavanagh K. The burden of HPV-associated anogenital cancers. Curr Oncol Rep. 2014;16(9):402.","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"1354_CR79","first-page":"390","volume":"61","author":"JA Kahn","year":"2012","unstructured":"Kahn JA, Burk RD, Squires KE, Kapogiannis BG, Rudy B, Xu J, et al. Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination. JAIDS. 2012;61(3):390\u20139.","journal-title":"JAIDS"},{"issue":"Suppl 5","key":"1354_CR80","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","volume":"30","author":"D Forman","year":"2012","unstructured":"Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(Suppl 5):F12\u201323.","journal-title":"Vaccine."},{"issue":"348","key":"1354_CR81","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"2003","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;2003(348):518\u201327.","journal-title":"N Engl J Med."},{"issue":"4","key":"1354_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0152828","volume":"11","author":"EA Oga","year":"2016","unstructured":"Oga EA, Schumaker LM, Alabi BS, Obaseki D, Umana A, Bassey I-A, et al. Paucity of HPV-related head and neck cancers (HNC) in Nigeria. PLoS ONE. 2016;11(4):1\u20139.","journal-title":"PLoS ONE."},{"issue":"1","key":"1354_CR83","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1158\/1940-6207.CAPR-11-0542","volume":"5","author":"R Lowy","year":"2012","unstructured":"Lowy R, Schiller JT. Reducing HPV-associated cancer globally. Cancer Prevention Res (Philadelphia, Pa). 2012;5(1):18\u201323.","journal-title":"Cancer Prevention Res (Philadelphia, Pa)"},{"issue":"4","key":"1354_CR84","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/lary.25767","volume":"126","author":"Z Gooi","year":"2016","unstructured":"Gooi Z, Chan JY, Fakhry C. The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer. Laryngoscope. 2016;126(4):894\u2013900.","journal-title":"Laryngoscope."},{"issue":"suppl 4","key":"1354_CR85","first-page":"D1","volume":"30","author":"S De Sanjos\u00e9","year":"2012","unstructured":"De Sanjos\u00e9 S, Serrano B, Castellsagu\u00e9 X, Brotons M, Mu\u00f1oz J, Bruni L, et al. Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. WHO\/ICO HPV Information Centre Report. Vaccine. 2012;30(suppl 4):D1\u2013D83.","journal-title":"Vaccine"},{"issue":"7","key":"1354_CR86","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/OLQ.0b013e31828fcf57","volume":"40","author":"TB Olesen","year":"2013","unstructured":"Olesen TB, Iftner T, Mwaiselage J, Kahesa C, Rasch V, Ngoma T, et al. Prevalence and type distribution of human papillomavirus among 1813 men in Tanzania and the relationship to HIV status. Sexually Transmitted Diseases. 2013;40(7):592\u20138.","journal-title":"Sexually Transmitted Diseases."},{"key":"1354_CR87","doi-asserted-by":"crossref","unstructured":"Natunen K, Lehtinen J, Namujju P, Sellors J, Lehtinen M. Aspects of prophylactic vaccination against cervical cancer and other human papillomavirus-related cancers in developing countries. Infectious diseases in obstetrics and gynecology. 2011;2011.","DOI":"10.1155\/2011\/675858"},{"issue":"9","key":"1354_CR88","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1002\/ijc.27650","volume":"131","author":"M Arbyn","year":"2012","unstructured":"Arbyn M, De Sanjos\u00e9 S, Saraiya M, Sideri M, Palefsky J, Lacey C, et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. International journal of cancer. 2012;131(9):1969\u201382.","journal-title":"International journal of cancer."},{"issue":"2","key":"1354_CR89","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1525-1470.2010.01103.x","volume":"27","author":"KA Carroll","year":"2010","unstructured":"Carroll KA, Pierce J, Kovarik CL. Perianal Bowen disease in a child with human immunodeficiency virus. Pediatric Dermatology. 2010;27(2):166\u20139.","journal-title":"Pediatric Dermatology."},{"key":"1354_CR90","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1016\/j.vaccine.2013.10.003","volume":"31","author":"FX Bosch","year":"2013","unstructured":"Bosch FX, Broker TR, Forman D, Moscicki A-B, Gillison ML, Doorbar J, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31:H1\u2013H31.","journal-title":"Vaccine."},{"issue":"1","key":"1354_CR91","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11904-014-0254-4","volume":"12","author":"C Brickman","year":"2015","unstructured":"Brickman C, Palefsky JM. Human papillomavirus in the HIV-infected host: epidemiology and pathogenesis in the antiretroviral era. Curr HIV\/AIDS Rep. 2015;12(1):6\u201315.","journal-title":"Curr HIV\/AIDS Rep."},{"issue":"Suppl 5","key":"1354_CR92","doi-asserted-by":"publisher","first-page":"F32","DOI":"10.1016\/j.vaccine.2012.07.092","volume":"31","author":"H De Vuyst","year":"2013","unstructured":"De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, et al. The burden of human papillomavirus infections and related diseases in sub-Saharan Africa. Vaccine. 2013;31(Suppl 5):F32\u201346.","journal-title":"Vaccine."},{"issue":"3","key":"1354_CR93","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s11904-012-0128-6","volume":"9","author":"C Firnhaber","year":"2012","unstructured":"Firnhaber C, Wilkin T. Human papillomavirus vaccines: where do they fit in HIV-infected individuals? Current HIV\/AIDS Reports. 2012;9(3):278\u201386.","journal-title":"Current HIV\/AIDS Reports."},{"issue":"4","key":"1354_CR94","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/COH.0b013e328347335d","volume":"6","author":"I Heard","year":"2011","unstructured":"Heard I. Human papillomavirus, cancer and vaccination. Cur Opin HIV AIDS. 2011;6(4):297\u2013302.","journal-title":"Cur Opin HIV AIDS."},{"issue":"10","key":"1354_CR95","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/j.1365-3156.2009.02372.x","volume":"14","author":"KS Louie","year":"2009","unstructured":"Louie KS, De Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Tropical Medicine & International Health. 2009;14(10):1287\u2013302.","journal-title":"Tropical Medicine & International Health."},{"issue":"5","key":"1354_CR96","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/01.cco.0000239885.13537.36","volume":"18","author":"J Palefsky","year":"2006","unstructured":"Palefsky J. Human papillomavirus-related tumors in HIV. Current opinion in oncology. 2006;18(5):463\u20138.","journal-title":"Current opinion in oncology."},{"key":"1354_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-016-0090-9","volume":"11","author":"CD Capo-chichi","year":"2016","unstructured":"Capo-chichi CD, Aguida B, Chabi NW, Acapko-Ezin J, Sossah-Hiffo J, Agossou VK, et al. Diversity of high risk human papilloma viruses in women treated with antiretroviral and in healthy controls and discordance with cervical dysplasia in the South of Benin. Infect Agents Cancer. 2016;11:1\u20139.","journal-title":"Infect Agents Cancer."},{"key":"1354_CR98","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canep.2016.10.008","volume":"45","author":"EE Jedy-Agba","year":"2016","unstructured":"Jedy-Agba EE, Dareng EO, Adebamowo SN, Odutola M, Oga EA, Igbinoba F, et al. The burden of HPV associated cancers in two regions in Nigeria 2012\u20132014. Cancer Epidemiology. 2016;45:91\u20137.","journal-title":"Cancer Epidemiology."},{"key":"1354_CR99","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/ijc.21443","volume":"118","author":"SM Mbulaiteye","year":"2006","unstructured":"Mbulaiteye SM, Katabira ET, Wabinga H, et al. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS\u2013Cancer Registry Match Study. Int J Cancer. 2006;118:985\u201390.","journal-title":"Int J Cancer"},{"key":"1354_CR100","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1158\/1055-9965.EPI-08-0956","volume":"18","author":"RS Holmes","year":"2009","unstructured":"Holmes RS, Hawes SE, Toure\u2019 P, et al. HIV infection as a risk factor for cervical cancer and cervical intraepithelial neoplasia in Senegal. Cancer Epidemiol Biomarkers Prev. 2009;18:2442\u20136.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1354_CR101","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1097\/AOG.0b013e3181743327","volume":"111","author":"L Denny","year":"2008","unstructured":"Denny L, Boa R, Williamson A, et al. Human papillomavirus infection and cervical disease in human immunodeficiency virus infected women. Obstel Gynaecol. 2008;111:1380\u20137.","journal-title":"Obstel Gynaecol."},{"key":"1354_CR102","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/sj.bjc.6603737","volume":"96","author":"V Sahasrabuddhe","year":"2007","unstructured":"Sahasrabuddhe V, Mwanahamuntu MH, Vermund SH, et al. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Canc. 2007;96:1480\u20133.","journal-title":"Br J Canc."},{"key":"1354_CR103","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000325079","volume":"53","author":"C Firnhaber","year":"2009","unstructured":"Firnhaber C, Zungu K, Levin S, et al. Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus infected women in Johannesburg. South Africa ACTA Cytological. 2009;53:10\u20137.","journal-title":"South Africa ACTA Cytological."},{"key":"1354_CR104","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJM199711063371903","volume":"337","author":"XW Sun","year":"1997","unstructured":"Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997;337:1343\u20139.","journal-title":"N Engl J Med"},{"key":"1354_CR105","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S0002-9378(98)70535-6","volume":"178","author":"H Minkoff","year":"1998","unstructured":"Minkoff H, Feldman J, DeHovitz J, Landesman S, Burk R. A longitudinal study of human papillomavirus carriage in human immunodeficiency virus infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol. 1998;178:982\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"1354_CR106","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/00007435-200208000-00001","volume":"29","author":"MJ Silverberg","year":"2002","unstructured":"Silverberg MJ, Ahdieh L, Munoz A, Anastos K, Burk RD, Cu-Uvin S, et al. The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis. 2002;29:427\u201335.","journal-title":"Sex Transm Dis"},{"key":"1354_CR107","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jmv.20244","volume":"75","author":"AK Chaturvedi","year":"2005","unstructured":"Chaturvedi AK, Dumestre J, Gaffga AM, Mire KM, Clark RA, Braly PS, et al. Prevalence of human papillomavirus genotypes in women from three clinical settings. J Med Virol. 2005;75:105\u201313.","journal-title":"J Med Virol"},{"key":"1354_CR108","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/jnci\/dji073","volume":"97","author":"HD Strickler","year":"2005","unstructured":"Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005;97:577\u201386.","journal-title":"J Natl Cancer Inst"},{"key":"1354_CR109","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0029-7844(96)00377-8","volume":"89","author":"A Olaitan","year":"1997","unstructured":"Olaitan A, Mocroft A, McCarthy K, Phillips A, ReidW JM. Cervical abnormality and sexually transmitted disease screening in human immunodeficiency virus-positive women. Obstet Gynecol. 1997;89:71\u20135.","journal-title":"Obstet Gynecol"},{"key":"1354_CR110","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1006\/gyno.1998.4938","volume":"68","author":"M Maiman","year":"1998","unstructured":"Maiman M, Fruchter RG, Sedlis A, Feldman J, Chen P, Burk RD, et al. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol. 1998;68:233\u20139.","journal-title":"Gynecol Oncol"},{"key":"1354_CR111","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1097\/00002030-200008180-00013","volume":"14","author":"MC Delmas","year":"2000","unstructured":"Delmas MC, Larsen C, van Benthem B, Hamers FF, Bergeron C, Poveda JD, et al. Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women. AIDS. 2000;14:1775\u201384.","journal-title":"AIDS"},{"key":"1354_CR112","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/oxfordjournals.aje.a010165","volume":"151","author":"L Ahdieh","year":"2000","unstructured":"Ahdieh L, Munoz A, Vlahov D, Trimble CL, Timpson LA, Shah K. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol. 2000;151:1148\u201357.","journal-title":"Am J Epidemiol"},{"key":"1354_CR113","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1258\/0956462991913583","volume":"10","author":"MA Gonc alves","year":"1999","unstructured":"Gonc alves MA, Massad E, Burattini MN, Villa LL. Relationship between human papillomavirus (HPV) genotyping and genital neoplasia in HIV-positive patients of Santos City, Sao Paulo, Brazil. Int J STD AIDS. 1999;10:803\u20137.","journal-title":"Int J STD AIDS"},{"key":"1354_CR114","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/jnci\/91.3.226","volume":"91","author":"JM Palefsky","year":"1999","unstructured":"Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst. 1999;91:226\u201336.","journal-title":"J Natl Cancer Inst"},{"key":"1354_CR115","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/jama.283.8.1031","volume":"283","author":"TV Ellerbrock","year":"2000","unstructured":"Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. J Am Med Assoc. 2000;283:1031\u20137.","journal-title":"J Am Med Assoc"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-020-01354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-020-01354-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-020-01354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T20:13:05Z","timestamp":1619035985000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-020-01354-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":115,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1354"],"URL":"https:\/\/doi.org\/10.1186\/s13643-020-01354-1","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]},"assertion":[{"value":"27 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This paper is a scoping review which strictly relied on the review of existing literature. Since there were no animal or human participants in this study, ethical approval is not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}